Characteristics of HIV-1 Non-B Subtype Infections in Northwest Poland

被引:18
作者
Parczewski, Milosz [1 ]
Leszczyszyn-Pynka, Magdalena [1 ]
Bander, Dorota [1 ]
Urbanska, Anna [1 ]
Stanczak, Grzegorz [2 ]
Boron-Kaczmarska, Anna [1 ]
机构
[1] Pomeranian Med Univ, Dept Infect Dis & Hepatol, PL-71455 Szczecin, Poland
[2] Hosp Infect Dis, Mol Diagnost Lab, Warsaw, Poland
关键词
HIV subtype D; non-B subtypes; HIV transmission; phylogenetic analysis; Poland; DRUG-RESISTANCE; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; HIGH PREVALENCE; TYPE-1; SUBTYPE; VIRUS; IMMIGRANTS; INCREASE; EUROPE;
D O I
10.1002/jmv.21797
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The number of non-B subtype HIV-1 infections in Europe has been increasing even though major regional differences have been observed. This trend was investigated in northwestern Poland using sequence and epidemiological data from a cohort of 102 HIV-1-infected patients from Szczecin, Poland. HIV-1 subtypes were defined by phylogenetic analysis of viral reverse transcriptase- and protease-partial coding regions, and results were compared with online subtyping by Standford and REGA tools. Subtype analysis using on-line subtyping methods produced varying results if compared to phylogenesis, with concordant variant assignment obtained for 98% (100/102) of sequences by Stanford and 85% (87/102) by REGA. In the population studied, non-B subtype infections comprised 21% of the infections and consisted of subtype D (57%, n=12), CRF01_AE (19%, n=4), A and Cclades (9.5%, n=2), and the CRF13_cpx recombinant isolate (4.8%, n=1). Patients carrying non-B subtypes were predominantly heterosexuals with high percentage (57%) of women observed in the group. All HIV-1 non-B women were Caucasian with majority (83%) of infections acquired in Poland; however, among 12 travelers included in the study a higher proportion of non-B infections was noted (50%, P=0.01). Moreover, lower baseline lymphocyte CD4 counts (P=0.01), higher baseline HIV-1 viremia (P=0.08), and a more advanced stage of the disease (P=0.03) were observed among individuals infected with non-B subtypes. The data indicated that the proportion of HIV-1 non-B subtype infections was higher than previously reported in Poland consisting of a high subtype D prevalence. Furthermore, subtype D transmission occurred primarily between heterosexual Caucasian individuals from this region. J. Med. Virol. 82:1306-1313, 2010. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:1306 / 1313
页数:8
相关论文
共 28 条
[1]   Late diagnosis of HIV in Europe: definitional and public health challenges [J].
Adler, A. ;
Mounier-Jack, S. ;
Coker, R. J. .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2009, 21 (03) :284-293
[2]   HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads [J].
Baeten, Jared M. ;
Chohan, Bhavna ;
Lavreys, Ludo ;
Chohan, Vrasha ;
McClelland, R. Scott ;
Certain, Laura ;
Mandaliya, Kishorchandra ;
Jaoko, Walter ;
Overbaugh, Julie .
JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (08) :1177-1180
[3]  
Bander Dorota, 2009, Przegl Epidemiol, V63, P61
[4]   Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes [J].
Beddows, S ;
Galpin, S ;
Kazmi, SH ;
Ashraf, A ;
Johargy, A ;
Frater, AJ ;
White, N ;
Braganza, R ;
Clarke, J ;
McClure, M ;
Weber, JN .
JOURNAL OF MEDICAL VIROLOGY, 2003, 70 (03) :337-342
[5]  
Bocket L, 2005, ANTIVIR THER, V10, P247
[6]  
Böni J, 1999, J ACQ IMMUN DEF SYND, V22, P174
[7]   Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France [J].
Chaix, ML ;
Descamps, D ;
Harzic, M ;
Schneider, W ;
Deveau, C ;
Tamalet, C ;
Pellegrin, I ;
Izopet, J ;
Ruffault, A ;
Masquelier, B ;
Meyer, L ;
Rouzioux, C ;
Brun-Vezinet, F ;
Costagliola, D .
AIDS, 2003, 17 (18) :2635-2643
[8]  
Czarkowski MP, 2007, INFECT DIS POISONING
[9]  
*EUR CTR EP MON HI, 2007, 75 EUR CTR EP MON HI
[10]   HIV-1 subtypes: epidemiology and significance fov HIV management [J].
Geretti, AM .
CURRENT OPINION IN INFECTIOUS DISEASES, 2006, 19 (01) :1-7